| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068404A1 Method for producing optically active dihydropyrones |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068395A1 Hiv inhibiting n-aminoimidazole derivatives |
| 09/06/2002 | WO2002068058A2 Dapd combination therapy with imdph inhibitors such as ribavirin or mycophenolic acid |
| 09/06/2002 | WO2002068015A2 Modular infusion device and method |
| 09/06/2002 | WO2002067990A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067985A1 Method for prophylaxis and treatment of porcine reproductive and respiratory syndrome |
| 09/06/2002 | WO2002067984A2 Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection |
| 09/06/2002 | WO2002067983A1 Novel vaccine |
| 09/06/2002 | WO2002067961A2 Therapeutic uses of herbal compositions |
| 09/06/2002 | WO2002067960A1 Herbal compositions useful as chemopreventive and therapeutic agents |
| 09/06/2002 | WO2002067955A2 A process for the manufacture of a herbal composition comprising a matrine |
| 09/06/2002 | WO2002067952A1 Prophylactic teat treatment |
| 09/06/2002 | WO2002067951A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 09/06/2002 | WO2002067950A1 Vascular regeneration promoters |
| 09/06/2002 | WO2002067943A1 Oral pharmaceutical composition of cefpodoxime proxetil |
| 09/06/2002 | WO2002067920A1 Remedies for chronic hepatitis c |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | WO2002067908A1 Novel dendritic polymers and their biomedical uses |
| 09/06/2002 | WO2002067906A1 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002067760A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 09/06/2002 | WO2002055079A3 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 09/06/2002 | WO2002055059A3 Method for preparing submicron particle suspensions |
| 09/06/2002 | WO2002050029A3 Tetracyclic derivatives as spla2 inhibitors |
| 09/06/2002 | WO2002050024A3 Thiazolidinediones |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002046183A3 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002028860A3 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 09/06/2002 | WO2002026728A3 Antiviral methods and compounds |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2002012250A3 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 09/06/2002 | WO2002011746A3 Chlorella preparations exhibiting immunomodulating properties |
| 09/06/2002 | WO2002008449A3 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/06/2002 | WO2002005796A3 Use of a spla2 inhibitor for the treatment of sepsis |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2002000687A3 Antimicrobial peptides and methods of use thereof |
| 09/06/2002 | WO2001098334A3 Streptococcus antigens |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | WO2001092562A3 Inhibiting retroviral integration by targeting the atm pathway |
| 09/06/2002 | WO2001070203A3 Agent for treating hepatitis c containing ukrain |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001024792A9 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 09/06/2002 | WO2001002024A9 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | CA2439465A1 Prophylactic teat treatment |
| 09/06/2002 | CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | CA2439335A1 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | CA2439303A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | CA2439150A1 Avilamycin derivatives |
| 09/06/2002 | CA2439053A1 Hiv inhibiting n-aminoimidazole derivatives |
| 09/06/2002 | CA2438960A1 Influenza vaccine formulations for intradermal delivery |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | CA2438696A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2438193A1 Novel dendritic polymers and their biomedical uses |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | CA2432287A1 Dapd combination therapy with inosine monophosphate dehydrogenase inhibitor |
| 09/06/2002 | CA2430702A1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/05/2002 | US20020123637 Pharmaceutically active compounds and methods of use thereof |
| 09/05/2002 | US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123618 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, thyroid and grave's disease |
| 09/05/2002 | US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123505 Stents, catheters, arterio-venous grafts, by-pass grafts and drug delivery ballons with surface coating containing a rapamycin derivative having a tetrazole group |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123471 Useful as a gene transfer vehicle for gene therapy, i.e. of the central nervous system |
| 09/05/2002 | US20020123468 Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020123041 Method for treatment of canine distemper |
| 09/05/2002 | US20020123039 Peptide for use in the prevention and treatment of vial infections |
| 09/05/2002 | US20020122817 Solid instant-release forms of administration and process for producing the same |
| 09/05/2002 | US20020122814 Nitric oxide associated with and releasable from a polyurea network formed from reaction (a) a polyisocyanate; (b) an amine donor; (c) an isocyanatosilane adduct having a terminal isocyanate group and an alkoxysilane group |
| 09/05/2002 | US20020122808 Combination of outer-polysaccharides extracted from Brucella comprises "A" outer-polysaccharide and "M" outer-polysaccharide and "R" protein antigens. |
| 09/05/2002 | US20020122805 Molecular conjugate comprising (a) a photosensitizer and (b) a targeting moiety, wherein the targeting moiety targets the conjugate to the intracellular pathogen or to an infected host cell. |
| 09/05/2002 | US20020122804 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 09/05/2002 | US20020122794 Antigenic preparation for treatment or prevention of helicobacter infection |
| 09/05/2002 | DE10111160A1 Neue Catecholat-ß-Laktamkonjugate, Verfahren zu ihrer Herstellung und ihre Anwendung New cathecolate ß-Laktamkonjugate, processes for their preparation and their use |
| 09/05/2002 | DE10109280A1 Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen Indole derivatives having an inhibitory effect on protein kinases |
| 09/05/2002 | DE10108470A1 Verfahren zur Herstellung optisch aktiver Dihydropyrone A process for preparing optically active dihydropyrones |
| 09/05/2002 | DE10107663A1 Testosteronhaltiges transdermales therapeutisches System und Verfahren zu seiner Herstellung Testosterone-containing transdermal therapeutic system and process for its preparation |
| 09/05/2002 | DE10107659A1 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin Mucoadhesive disintegratable pharmaceutical preparation for drug delivery in veterinary and human medicine |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236729A1 Clavulanic acid aldehyde, beta-lactamase inhibitor |
| 09/04/2002 | EP1236476A1 Medicinal compositions for oral use |
| 09/04/2002 | EP1236472A1 Glycyrrhizin preparations for transmucosal absorption |